Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia

B M Frost; E Forestier; G Gustafsson; P Nygren; M Hellebostad; G Jonmundsson; J Kanerva; K Schmiegelow; R Larsson; G Lönnerholm; Nordic Society for Paediatric Haematology and Oncology

doi:10.1038/sj.leu.2403540

Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia

B M Frost
, E Forestier
, G Gustafsson
, P Nygren
, M Hellebostad
, G Jonmundsson
, J Kanerva
, K Schmiegelow
, R Larsson
, G Lönnerholm
, Nordic Society for Paediatric Haematology and Oncology

Afdeling for Børn og Unge JMC

19 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Leukemia
Vol/bind	19
Udgave nummer	1
Sider (fra-til)	165-9
Antal sider	5
ISSN	0887-6924
DOI	https://doi.org/10.1038/sj.leu.2403540
Status	Udgivet - jan. 2005

Adgang til dokumentet

10.1038/sj.leu.2403540

Citationsformater

Frost, B. M., Forestier, E., Gustafsson, G., Nygren, P., Hellebostad, M., Jonmundsson, G., Kanerva, J., Schmiegelow, K., Larsson, R., Lönnerholm, G., & Nordic Society for Paediatric Haematology and Oncology (2005). Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia, 19(1), 165-9. https://doi.org/10.1038/sj.leu.2403540

Frost, BM, Forestier, E, Gustafsson, G, Nygren, P, Hellebostad, M, Jonmundsson, G, Kanerva, J, Schmiegelow, K, Larsson, R, Lönnerholm, G & Nordic Society for Paediatric Haematology and Oncology 2005, 'Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia', Leukemia, bind 19, nr. 1, s. 165-9. https://doi.org/10.1038/sj.leu.2403540

@article{8c5556c6eac441bcad308ef6fa9a1b4d,

title = "Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia",

keywords = "Adolescent, Antineoplastic Agents/therapeutic use, Bone Marrow Transplantation, Child, Child, Preschool, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 19, Combined Modality Therapy, Disease-Free Survival, Drug Resistance, Neoplasm/genetics, Female, Humans, In Situ Hybridization, Fluorescence, Infant, Karyotyping, Male, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Reverse Transcriptase Polymerase Chain Reaction, Translocation, Genetic",

author = "Frost, \{B M\} and E Forestier and G Gustafsson and P Nygren and M Hellebostad and G Jonmundsson and J Kanerva and K Schmiegelow and R Larsson and G L{\"o}nnerholm and \{Nordic Society for Paediatric Haematology and Oncology\}",

year = "2005",

month = jan,

doi = "10.1038/sj.leu.2403540",

language = "English",

volume = "19",

pages = "165--9",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia

AU - Frost, B M

AU - Forestier, E

AU - Gustafsson, G

AU - Nygren, P

AU - Hellebostad, M

AU - Jonmundsson, G

AU - Kanerva, J

AU - Schmiegelow, K

AU - Larsson, R

AU - Lönnerholm, G

AU - Nordic Society for Paediatric Haematology and Oncology

PY - 2005/1

Y1 - 2005/1

KW - Adolescent

KW - Antineoplastic Agents/therapeutic use

KW - Bone Marrow Transplantation

KW - Child

KW - Child, Preschool

KW - Chromosomes, Human, Pair 1

KW - Chromosomes, Human, Pair 19

KW - Combined Modality Therapy

KW - Disease-Free Survival

KW - Drug Resistance, Neoplasm/genetics

KW - Female

KW - Humans

KW - In Situ Hybridization, Fluorescence

KW - Infant

KW - Karyotyping

KW - Male

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy

KW - Reverse Transcriptase Polymerase Chain Reaction

KW - Translocation, Genetic

U2 - 10.1038/sj.leu.2403540

DO - 10.1038/sj.leu.2403540

M3 - Letter

C2 - 15526029

SN - 0887-6924

VL - 19

SP - 165

EP - 169

JO - Leukemia

JF - Leukemia

IS - 1

ER -